RE: Looking forward to the webinar.15 May 2025 17:52
I think it might be focused on the Company's recent data presentations on its proprietary pre|CISION® candidates FAP-Dox (AVA6000) and FAP-EXd (AVA6103) at the American Association for Cancer Research (AACR) Annual Meeting in Chicago, USA.
That's just a wild guess though